Infection and autoimmune liver diseases

Basit Öğe Kaydı
dc.authorid0000-0003-2359-4959
dc.contributor.authorSmyk, Daniel S.
dc.contributor.authorRigopoulou, Eirini I.
dc.contributor.authorDarkhabani, Mohammad
dc.contributor.authorInvernizzi, Pietro
dc.contributor.authorBogdanos, Dimitrios P.
dc.date.accessioned2024-05-16T07:18:16Z
dc.date.available2024-05-16T07:18:16Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractAutoimmune liver diseases (AiLD) comprise a heterogeneous group of disorders inflicting damage to the liver. Those diseases are characterized by an immune-mediated destruction of the hepatocytes (autoimmune hepatitis, AIH) or the biliary epithelial cells [primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)]. At times, overlapping features of AIH and PBC or AIH and PSC are noted in an insignificant number of affected patients. The pathogenesis and pathophysiological mechanisms responsible for the initial induction and subsequent progression of liver impairment are largely undefined but genetic, epigenetic, immunological, and environmental factors appear to be essential. Among various environmental triggers, infectious triggers have been incriminated largely with the development of PBC and AIH and to a lesser extent with PSC. The link between pathogens and PSC remains less defined, though the input of microbiome alterations has been considered imperative. The most common mechanism connecting infectious agents of any kind, whether microbes, viruses, or parasites, with AiLD is based on the assumption that molecular mimicry and immunological cross-reactivity involving exogenous and self-mimicking antigenic targets are heavily operated linking to liver autoimmunity in the form of auto-antibodies and indeed overt clinical disease, which can lead to hepatic failure. This chapter will underline the existing data on the involvement of infectious agents, which have been investigated in PBC and AIH.
dc.identifier.citationSmyk, D. S., Rigopoulou, E. I., Darkhabani, M., Invernizzi, P. ve Bogdanos, D. P. (2024). Infection and autoimmune liver diseases. Infection and Autoimmunity (Third Edition) içinde (857-875. ss.). Academic Press. http://dx.doi.org/10.1016/B978-0-323-99130-8.00025-8
dc.identifier.doi10.1016/B978-0-323-99130-8.00025-8
dc.identifier.endpage875
dc.identifier.isbn9780323991308
dc.identifier.isbn9780323991315
dc.identifier.scopus2-s2.0-85189600747
dc.identifier.scopusqualityN/A
dc.identifier.startpage857
dc.identifier.urihttp://dx.doi.org/10.1016/B978-0-323-99130-8.00025-8
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12463
dc.indekslendigikaynakScopus
dc.institutionauthorDarkhabani, Mohammad
dc.language.isoen
dc.publisherAcademic Press
dc.relation.ispartofInfection and Autoimmunityen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAutoimmune Hepatitis
dc.subjectAutoimmune Liver Diseases
dc.subjectPrimary Biliary Cholangitis
dc.titleInfection and autoimmune liver diseases
dc.typeBook Chapter

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Kitap Bölümü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu